Page last updated: 2024-10-25

cisapride and Duodenal Ulcer

cisapride has been researched along with Duodenal Ulcer in 1 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.

Research Excerpts

ExcerptRelevanceReference
"In a single centre double blind study of 66 patients, the value of cisapride (10 mg twice daily) was compared with placebo in the prevention of duodenal ulcer relapse."9.07Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse. ( Johnson, AG; Kerrigan, DD; Read, NW; Taylor, ME, 1993)
"In a single centre double blind study of 66 patients, the value of cisapride (10 mg twice daily) was compared with placebo in the prevention of duodenal ulcer relapse."5.07Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse. ( Johnson, AG; Kerrigan, DD; Read, NW; Taylor, ME, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kerrigan, DD1
Taylor, ME1
Read, NW1
Johnson, AG1

Trials

1 trial available for cisapride and Duodenal Ulcer

ArticleYear
Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.
    Gut, 1993, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Cisapride; Confidence Intervals; Double-Blind Method; Du

1993